No Image
Polyclonal Antibodies
[KO Validated] Anti-IRF9 Polyclonal Antibody for WB, ELISA - Q00978
Item Number : CM0021460
Price varies based on specs and customizations
- Application
- WB, ELISA
- Cross Reactivity
- Human
- Protein Weight
- 44kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | [KO Validated] IRF9 Rabbit pAb |
| Remarks/Alias | p48; IRF-9; ISGF3; ISGF3G; F9 |
| Species | Human |
| Gene ID | 10379 |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 113-255 of human IRF9 (NP_006075.3) |
| Source | Rabbit |
| Category | Polyclonal Antibodies |
| Application | WB, ELISA |
| Cross Reactivity | Human |
| SWISS | Q00978 |
| Protein Weight | 44kDa |
| Shipping | Ice bag |
Biological Background: IRF9 Function and Localization
- IRF9 (Interferon regulatory factor 9), also known as ISGF3γ or p48, is a key transcription factor in the type I interferon (IFN-α/β) signaling pathway.
- Upon type I IFN binding to cell surface receptors, kinases TYK2 and JAK1 are activated, leading to tyrosine phosphorylation of STAT1 and STAT2.
- IRF9 associates with phosphorylated STAT1:STAT2 dimer to form the ISGF3 complex, which translocates to the nucleus.
- In the nucleus, ISGF3 binds to the interferon-stimulated response element (ISRE) to drive transcription of interferon-stimulated genes (ISGs), inducing an antiviral state.
- IRF9 belongs to the interferon regulatory factor family and is critical for innate antiviral immunity.
- Subcellularly, IRF9 shuttles between the cytoplasm and nucleus; its nuclear accumulation is enhanced upon IFN signaling.
- Post-translational modifications include phosphorylation and ubiquitin-like conjugation, which may regulate its activity and stability.
Experimental Guidance and Technical Tips
- The antibody is identified as KO-validated by the supplier; use this feature to confirm specificity in your own experimental setup.
- For Western blot, a band around 44 kDa is expected; include both positive (e.g., IFN-treated human cells) and negative controls.
- In ELISA, optimize coating conditions and antibody concentrations for your specific assay format.
- Being a polyclonal preparation, lot-to-lot consistency should be verified if used in quantitative or diagnostic applications.
- The immunogen covers amino acids 113–255, so the antibody may recognize multiple IRF9 isoforms sharing this epitope; verify in your sample context.
- When using out-of-species from the validated human cross-reactivity, perform preliminary testing to confirm reactivity.
CamelBio: Your One-Stop Sourcing Bridge
CamelBio is your dedicated one-stop partner for IVD raw-material sourcing, from validated antibody pairs to bulk ancillary reagents. This anti-IRF9 polyclonal antibody supports research into interferon signaling and innate immunity, critical areas for diagnostic development. Trust our integrated supply chain to deliver consistent, high-quality materials for your projects, from concept to clinic.
Product Datasheet
[KO Validated] Anti-IRF9 Polyclonal Antibody for WB, ELISA - Q00978
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!